The present study showed that metformin decreased DNMT expression at the transcriptional or post-transcriptional level through upregulation of miR-148/-152 family members in NSCLC cells (Additional file 10), suggesting that metformin has potential as a DNMT inhibitor. The gene discussed is DNMT1; the disease is non-small cell lung carcinoma.